Form 8-K - Current report:
SEC Accession No. 0001493152-24-030491
Filing Date
2024-08-07
Accepted
2024-08-07 08:00:19
Documents
15
Period of Report
2024-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51080
2 ex3-1.htm EX-3.1 12414
3 ex10-1.htm EX-10.1 46518
  Complete submission text file 0001493152-24-030491.txt   299924

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE shph-20240805.xsd EX-101.SCH 3030
5 XBRL LABEL FILE shph-20240805_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE shph-20240805_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3934
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 241181498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)